(Updated - March 27, 2026 4:16 PM EDT)

Jefferies analyst Faisal Khurshid downgraded PTC Therapeutics (NASDAQ: PTCT) from Buy ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE